Last updated on May 2018

Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo

Brief description of study

The main purpose of this study is to evaluate the effect on mental state (known as "neurocognitive function") with use of Praluent.

Clinical Study Identifier: NCT02957682

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Administrator

Rocky Mount, NC United States